Leukemia
Showing NaN - NaN of 143
Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Cytokine-Induced Memory-like Natural Killer Cells
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 22, 2023
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,
Not yet recruiting
- Acute Myeloid Leukemia
- +5 more
- Cytokine Induced Memory-like Natural Killer Cells
- Interleukin-2
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sleep ALL Night)
Not yet recruiting
- Pediatric Acute Lymphoblastic Leukemia
- +2 more
- Sleep ALL Night
-
Boston, Massachusetts
- +1 more
May 10, 2023
Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)
Not yet recruiting
- Myeloproliferative Disorders
- Leukemia
- Cardiac Lifestyle Program
-
Boston, Massachusetts
- +2 more
May 1, 2023
Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)
Recruiting
- Hematologic Malignancy
- +4 more
- Palliative Care
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)
Active, not recruiting
- Leukemia
- +7 more
- Decitabine
- +3 more
-
Boston, Massachusetts
- +10 more
Jan 19, 2023
Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)
Completed
- Leukemia
- arsenic trioxide
- +4 more
-
Roseville, California
- +191 more
Dec 14, 2022
Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer Trial in Worldwide (Venetoclax, Ibrutinib)
Completed
- Leukemia
- +2 more
-
Boston, Massachusetts
- +14 more
Nov 23, 2022
Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma
Recruiting
- Clinical Stage I Cutaneous Melanoma AJCC v8
- +33 more
- Informational Intervention
- +4 more
-
Los Angeles, California
- +4 more
Dec 14, 2022
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR
Active, not recruiting
- Leukemia
- KIR genotyping
- HLA genotyping
-
Tampa, Florida
- +9 more
Nov 29, 2022
Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- Leukemia
-
Tampa, Florida
- +4 more
Nov 11, 2022
Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,
Completed
- Drug/Agent Toxicity by Tissue/Organ
- Leukemia
- asparaginase
- +15 more
-
Boston, Massachusetts
- +9 more
Nov 9, 2022
Chronic Lymphocytic Leukemia, Leukemia Trial in United States (Ibrutinib, Fludarabine, Cyclophosphamide)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Leukemia
- Ibrutinib
- +3 more
-
Coral Gables, Florida
- +8 more
Sep 28, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Blood and Bone Marrow Samples in Chronic Myelogenous Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +3 more
-
San Diego, California
- +160 more
Aug 2, 2022
Tissue and Blood Samples From Acute Myeloid Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +7 more
-
Mountain View, California
- +76 more
Aug 2, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)
Active, not recruiting
- Hairy Cell Leukemia
- +2 more
-
New Haven, Connecticut
- +8 more
Feb 7, 2022
Hematologic Malignancy, Leukemia, Lymphoma Trial in Boston (CAR-37 T cells)
Recruiting
- Hematologic Malignancy
- +5 more
- CAR-37 T cells
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Oct 28, 2021